4-methylcatechol has been researched along with Pain, Chronic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukuhara, K; Ida, Y; Ishikawa, J; Ishikawa, K; Ishikawa, T; Iwanaga, Y; Kakeda, T; Ono, M; Yamagata, H; Yasuda, S | 1 |
| Fukuhara, K; Ishikawa, K; Ishikawa, T; Kakeda, T; Kim, HK; Kishishita, Y; Norii, T; Yamamoto, M; Yasuda, S | 1 |
2 other study(ies) available for 4-methylcatechol and Pain, Chronic
| Article | Year |
|---|---|
4-Methylcatechol prevents derangements of brain-derived neurotrophic factor and TrkB-related signaling in anterior cingulate cortex in chronic pain with depression-like behavior.
Topics: Analgesics; Animals; Antidepressive Agents; Brain; Brain-Derived Neurotrophic Factor; Catechols; Chronic Pain; Depression; Extracellular Signal-Regulated MAP Kinases; Gyrus Cinguli; Hot Temperature; Hyperalgesia; Nerve Compression Syndromes; Neuropsychological Tests; Rats; Rats, Sprague-Dawley; Receptor, trkB; RNA, Messenger; Sciatic Nerve; Signal Transduction | 2014 |
Intracerebroventricular 4-methylcatechol (4-MC) ameliorates chronic pain associated with depression-like behavior via induction of brain-derived neurotrophic factor (BDNF).
Topics: Analgesics; Animals; Antidepressive Agents; Behavior, Animal; Benzamides; Brain-Derived Neurotrophic Factor; Catechols; Chronic Pain; Depression; Diphenylamine; Injections, Intraventricular; Rats; Rats, Sprague-Dawley; Reaction Time; Restraint, Physical | 2012 |